BRI and Novo Nordisk Collaborate on Autoimmune Disease Research

Novo Nordisk and Benaroya Research Institute at Virginia Mason (BRI), Seattle,Wash., have entered into a three year collaborative agreement to potentially speed up translational research of the diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease and lupus.

Gene Therapy May Reverse Hemophilia

In a recent study, researchers altered the DNA of a common virus so that it would instruct the bodies of hemophiliacs to make the Factor IX (FIX) protein, which helps blood clot.